Form S-3 COGNITION THERAPEUTICS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Cognition Therapeutics establishes $75 million stock offering program
December 18, 2025 4:22 PM ESTCognition Therapeutics Inc. (NASDAQ: CGTX) entered into an at-the-market equity offering agreement with Jefferies LLC on December 18, 2024, according to a company filing.
Under the sales agreement, Cognition Therapeutics may sell up to $75 million of its common stock through Jefferies, which will... More
Cognition Therapeutics, Inc. (CGTX) files $300M mixed shelf
December 18, 2025 4:09 PM ESTCognition Therapeutics, Inc. (NASDAQ: CGTX) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Subscription Rights
